Important information about compounded medications
Personalized compounded semaglutide and personalized compounded tirzepatide are not FDA-approved and are not equivalent to FDA-approved products.
The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed.
Compounding pharmacies are regulated by state boards of pharmacy for sterile compounding and are required to follow United States Pharmacopeia standards.
Treatment is not guaranteed. A licensed healthcare provider determines whether treatment is appropriate for each individual patient. Individual experiences and outcomes vary. If a patient is not qualified, a refund will be issued.
Bodi Envi is not a medical practice, pharmacy, or medication manufacturer. Brand names are trademarks of their respective owners.